Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Africa News Ledger.
Press releases published on August 25, 2025
ORYZON Receives European Medicines Agency Approval to Initiate a Phase Ib Study of Iadademstat in Sickle Cell Disease
GlobeNewswire
·
August 25, 2025
First iadademstat clinical trial in non-malignant hematological indications MADRID and CAMBRIDGE, Mass., Aug. 25, 2025 (GLOBE NEWSWIRE) -- Oryzon Genomics, S.A. (ISIN Code: ES0167733015, Ticker: ORY), a clinical-stage biopharmaceutical company and a …
BridgeBio to Present Additional Open-label Extension Data from ATTRibute-CM at ESC Congress 2025
GlobeNewswire
·
August 25, 2025
PALO ALTO, Calif., Aug. 25, 2025 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (Nasdaq: BBIO) (“BridgeBio” or the “Company”), a new type of biopharmaceutical company focused on genetic diseases, announced today that one rapid-fire oral presentation on …
Spectral Medical Receives US$3 Million From Vantive
GlobeNewswire
·
August 25, 2025
TORONTO, Aug. 25, 2025 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a late-stage theranostic company advancing therapeutic options for sepsis and septic shock, today announced that it has received the US$3 million …
Incyclix Bio Secures $11.25 Million Series B Extension to Advance the Phase 1/2 Clinical Trial of INX-315 in Patients with CDK4/6 Inhibitor Resistant ER+/HER2- Breast Cancer or CCNE1-Amplified Solid Tumors
GlobeNewswire
·
August 25, 2025
RESEARCH TRIANGLE PARK, N.C., Aug. 25, 2025 (GLOBE NEWSWIRE) -- Incyclix Bio, LLC, a next-generation cell cycle control company developing INX-315, a novel, potent and selective CDK2 inhibitor for the treatment of advanced and resistant cancer, today …
Major Drilling to Release Results for its First Quarter on September 8, 2025
GlobeNewswire
·
August 25, 2025
MONCTON, New Brunswick, Aug. 25, 2025 (GLOBE NEWSWIRE) -- Major Drilling Group International Inc. (TSX: MDI) (the “Company”) will release its first quarter results, ended July 31, 2025, on Monday, September 8, 2025 after the markets have closed. Webcast/ …
Apollo Expands Project Team; Receives Drill Permit for Calico Silver Project
GlobeNewswire
·
August 25, 2025
VANCOUVER, British Columbia, Aug. 25, 2025 (GLOBE NEWSWIRE) -- Apollo Silver Corp. (“Apollo” or the “Company”) (TSX.V:APGO, OTCQB:APGOF, Frankfurt:6ZF0) is pleased to announce a number of positive developments at its Calico Silver Project (“Calico” or the …
MEXC Launches Airdrop+ Event with 75,000 USDT Prize Pool to Celebrate Listing of Camp Network (CAMP)
GlobeNewswire
·
August 25, 2025
VICTORIA, Seychelles, Aug. 25, 2025 (GLOBE NEWSWIRE) -- MEXC, a leading global cryptocurrency exchange, today announced it will list Camp Network (CAMP) at 09:00 UTC on August 27, 2025. To celebrate the listing, MEXC is launching an Airdrop+ event …
Erdene Provides Update on Share Consolidation
GlobeNewswire
·
August 25, 2025
HALIFAX, Nova Scotia, Aug. 25, 2025 (GLOBE NEWSWIRE) -- Erdene Resource Development Corp. (TSX: ERD; MSE: ERDN; OTCQB: ERDCF) ("Erdene" or the "Company") is pleased to provide an update on the proposed consolidation (the "Consolidation") of Company's …
NorthWest Upsizes Flow Through Financing to $4.1 Million and Closes Final Tranche
GlobeNewswire
·
August 25, 2025
NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES TORONTO, Aug. 25, 2025 (GLOBE NEWSWIRE) -- NorthWest Copper Corp. (“NorthWest” or “the Company”) (TSX-V: NWST) is pleased to announce it has upsized a second …
Oculis Appoints Mark Kupersmith, M.D., and Sebastian Wolf, M.D., Ph.D., World-Renowned Neuro-Ophthalmology and Retina Experts, as Chief Medical Advisors
GlobeNewswire
·
August 25, 2025
Mark Kupersmith, M.D. appointed as Chief Medical Advisor, Neuro-Ophthalmology, following positive Phase 2 ACUITY trial results with Privosegtor (OCS-05) in acute optic neuritis and initiation of multiple programs in neuro-ophthalmology Sebastian Wolf, M.D …
Vaxxas secures ~A$90 million in funding to commercialise needle-free vaccination delivery technology
GlobeNewswire
·
August 25, 2025
Total equity and debt raising of ~$90 million provides runway to 2H 2027 Strong support from existing and new investors including SPRIM Global Investments Funds will be used to scale-up production of needle-free vaccination delivery technology Founding CEO …
HUTCHMED Announces Appointment of Acting Chief Executive Officer
GlobeNewswire
·
August 25, 2025
HONG KONG and SHANGHAI and FLORHAM PARK, N.J, Aug. 25, 2025 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited (“HUTCHMED”) (Nasdaq/AIM:HCM; HKEX:13) today announces that Dr Weiguo Su, an Executive Director of the Company, will take a leave of absence from his …